210 related articles for article (PubMed ID: 37558831)
1. The pharmacoepigenomic landscape of cancer cell lines reveals the epigenetic component of drug sensitivity.
Ohnmacht AJ; Rajamani A; Avar G; Kutkaite G; Gonçalves E; Saur D; Menden MP
Commun Biol; 2023 Aug; 6(1):825. PubMed ID: 37558831
[TBL] [Abstract][Full Text] [Related]
2. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
3. Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel.
Shen L; Kondo Y; Ahmed S; Boumber Y; Konishi K; Guo Y; Chen X; Vilaythong JN; Issa JP
Cancer Res; 2007 Dec; 67(23):11335-43. PubMed ID: 18056460
[TBL] [Abstract][Full Text] [Related]
4. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.
Zhu Y; Lu H; Zhang D; Li M; Sun X; Wan L; Yu D; Tian Y; Jin H; Lin A; Gao F; Lai M
Clin Epigenetics; 2018; 10():30. PubMed ID: 29507648
[TBL] [Abstract][Full Text] [Related]
5. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
[TBL] [Abstract][Full Text] [Related]
8. Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924).
Wong KM; Micel LN; Selby HM; Tan AC; Pitts TM; Bagby SM; Spreafico A; Klauck PJ; Blakemore SJ; Smith PF; McDonald A; Berger A; Tentler JJ; Eckhardt SG
Invest New Drugs; 2017 Feb; 35(1):11-25. PubMed ID: 27783255
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers.
Zhang J; Huang K
BMC Genomics; 2017 Jan; 18(Suppl 1):1045. PubMed ID: 28198667
[TBL] [Abstract][Full Text] [Related]
10. CpG island methylation profiling in human melanoma cell lines.
Tellez CS; Shen L; Estécio MR; Jelinek J; Gershenwald JE; Issa JP
Melanoma Res; 2009 Jun; 19(3):146-55. PubMed ID: 19441164
[TBL] [Abstract][Full Text] [Related]
11. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
[TBL] [Abstract][Full Text] [Related]
12. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA methylation analysis identifies promoter hypermethylation in canine malignant melanoma.
Ishizaki T; Yamazaki J; Jelinek J; Aoshima K; Kimura T
Res Vet Sci; 2020 Oct; 132():521-526. PubMed ID: 32810831
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics and Precision Oncology.
Werner RJ; Kelly AD; Issa JJ
Cancer J; 2017; 23(5):262-269. PubMed ID: 28926426
[TBL] [Abstract][Full Text] [Related]
15. Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma.
Xu R; Xu Q; Huang G; Yin X; Zhu J; Peng Y; Song J
Biomed Res Int; 2019; 2019():9379864. PubMed ID: 31956659
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
[TBL] [Abstract][Full Text] [Related]
17. Integrated omics profiling reveals novel patterns of epigenetic programming in cancer-associated myofibroblasts.
Najgebauer H; Liloglou T; Jithesh PV; Giger OT; Varro A; Sanderson CM
Carcinogenesis; 2019 Jun; 40(4):500-512. PubMed ID: 30624614
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma.
Falahat R; Berglund A; Putney RM; Perez-Villarroel P; Aoyama S; Pilon-Thomas S; Barber GN; Mulé JJ
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33827917
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic technologies for precision oncology.
Weichenhan D; Lipka DB; Lutsik P; Goyal A; Plass C
Semin Cancer Biol; 2022 Sep; 84():60-68. PubMed ID: 32822861
[TBL] [Abstract][Full Text] [Related]
20. Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis.
Kikutake C; Yahara K
PLoS One; 2016; 11(4):e0152918. PubMed ID: 27042856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
